Mozart Therapeutics lands $25M to develop therapies for autoimmune, inflammatory diseases New funding: Seattle biotech company Mozart Therapeutics announced $25 million in new funding Wednesday to further its development of therapies for… Read More
Tech Moves: Zillow VP joins OpenSea; Panopto hires Microsoft manager; product vet joins Binance — Loni Mahanta, formerly vice president of government relations & public policy for Zillow Group, joined NFT marketplace OpenSea in… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Founded last year, Mozart Therapeutics lands $55M to develop therapies for celiac and other diseases A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac… Read More
